BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16788846)

  • 1. Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients.
    Morari EC; Lima AB; Bufalo NE; Leite JL; Granja F; Ward LS
    J Cancer Res Clin Oncol; 2006 Aug; 132(8):521-8. PubMed ID: 16788846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype.
    Spurdle AB; Webb PM; Purdie DM; Chen X; Green A; Chenevix-Trench G
    Carcinogenesis; 2001 Jan; 22(1):67-72. PubMed ID: 11159743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival.
    Beeghly A; Katsaros D; Chen H; Fracchioli S; Zhang Y; Massobrio M; Risch H; Jones B; Yu H
    Gynecol Oncol; 2006 Feb; 100(2):330-7. PubMed ID: 16199080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells.
    Ueda M; Hung YC; Terai Y; Kanda K; Takehara M; Yamashita H; Yamaguchi H; Akise D; Yasuda M; Nishiyama K; Ueki M
    Hum Cell; 2003 Dec; 16(4):241-51. PubMed ID: 15147044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.
    Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
    To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile.
    Pereira D; Assis J; Gomes M; Nogueira A; Medeiros R
    Eur J Clin Pharmacol; 2016 May; 72(5):545-53. PubMed ID: 26803611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of p53 gene polymorphism with susceptibility to ovarian cancer].
    Kang S; Duan LH; Zhang JH; Guo W; Wang N; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):754-8. PubMed ID: 15634502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome.
    Medeiros R; Pereira D; Afonso N; Palmeira C; Faleiro C; Afonso-Lopes C; Freitas-Silva M; Vasconcelos A; Costa S; Osório T; Lopes C
    Int J Clin Oncol; 2003 Jun; 8(3):156-61. PubMed ID: 12851839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology.
    Kraggerud SM; Oldenburg J; Alnaes GI; Berg M; Kristensen VN; Fossa SD; Lothe RA
    Pharmacogenet Genomics; 2009 Oct; 19(10):751-9. PubMed ID: 19741569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression.
    Sarhanis P; Redman C; Perrett C; Brannigan K; Clayton RN; Hand P; Musgrove C; Suarez V; Jones P; Fryer AA; Farrell WE; Strange RC
    Br J Cancer; 1996 Dec; 74(11):1757-61. PubMed ID: 8956789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
    Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
    Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer.
    Howells RE; Redman CW; Dhar KK; Sarhanis P; Musgrove C; Jones PW; Alldersea J; Fryer AA; Hoban PR; Strange RC
    Clin Cancer Res; 1998 Oct; 4(10):2439-45. PubMed ID: 9796976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene.
    Gudmundsdottir K; Tryggvadottir L; Eyfjord JE
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1169-73. PubMed ID: 11700265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype.
    García-González MA; Quintero E; Bujanda L; Nicolás D; Benito R; Strunk M; Santolaria S; Sopeña F; Badía M; Hijona E; Pérez-Aísa MA; Méndez-Sánchez IM; Thomson C; Carrera P; Piazuelo E; Jiménez P; Espinel J; Campo R; Manzano M; Geijo F; Pellisé M; González-Huix F; Espinós J; Titó L; Zaballa M; Pazo R; Lanas A
    Mutagenesis; 2012 Nov; 27(6):771-7. PubMed ID: 22952149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome.
    Gadducci A; Di Cristofano C; Zavaglia M; Giusti L; Menicagli M; Cosio S; Naccarato AG; Genazzani AR; Bevilacqua G; Cavazzana AO
    Anticancer Res; 2006; 26(1B):687-93. PubMed ID: 16739339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
    Huang ZH; Hua D; Du X
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
    Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
    Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.